Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$17.91 - $52.25 $340,755 - $994,108
-19,026 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$66.92 - $84.79 $415,573 - $526,545
6,210 Added 48.46%
19,026 $1.6 Million
Q3 2021

Nov 15, 2021

BUY
$46.83 - $73.5 $409,294 - $642,390
8,740 Added 214.43%
12,816 $854,000
Q2 2021

Aug 16, 2021

BUY
$37.41 - $62.25 $152,483 - $253,731
4,076 New
4,076 $217,000

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $178M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.